Good afternoon :)
Switch to
Place Order

Venus Remedies Ltd

VENUSREM
Health CarePharmaceuticals
SmallcapWith a market cap of ₹609 cr, stock is ranked 1,108
High RiskStock is 3.45x as volatile as Nifty
469.1013.05 (+2.86%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹609 cr, stock is ranked 1,108
High RiskStock is 3.45x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
9.87
PB RatioPB Ratio
1.52
Dividend YieldDiv. Yield
Sector PESector PE
40.27
Sector PBSector PB
5.39
Sector Div YldSctr Div Yld
0.64%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Venus Remedies Limited is engaged in pharmaceutical product manufacturing business. The Company provides formulations and manufactures dosage injectables.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Financial TrendFinancial statements 

2018201920202021374.66327.98375.99600.36-30.70-28.58-10.0061.76
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Increased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has increased by 4.92%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Shareholders meeting 
Announced OnSep 21, 2021

Venus Remedies Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 20, 2021. Further, the company has informed the Exchange regarding voting results. | Download

Venus Remedies Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 20, 2021. Further, the company has informed the Exchange regarding voting results. | Download

Shareholders meeting 
Announced OnSep 20, 2021

Venus Remedies Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 20, 2021 | Download

Venus Remedies Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 20, 2021 | Download

Cash Dividend 
Ex. DateSep 23, 2013

Final • Div/Share: ₹ 3

See all events